127 related articles for article (PubMed ID: 7826682)
1. Elimination studies of antipyrine and its metabolites in healthy Saudi Arabians.
Ali HA; el-Yazigi A; Sieck JO; Døssing M; Saour J; Raines DA; Ernst P
Hum Exp Toxicol; 1994 Oct; 13(10):658-62. PubMed ID: 7826682
[TBL] [Abstract][Full Text] [Related]
2. Elimination of antipyrine and its metabolites in interferon treated hepatitis C.
Sieck JO; el-Yazigi A; Ali H; Døssing M; Saour J; Raines DA; Ernst P
Hum Exp Toxicol; 1994 Sep; 13(9):598-601. PubMed ID: 7986571
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
St Peter JV; Abul-Hajj Y; Awni WM
Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
[TBL] [Abstract][Full Text] [Related]
4. Antipyrine pharmacokinetics and urinary excretion in female horses.
Dyke TM; Sams RA; Hinchcliff KW
Am J Vet Res; 1998 Mar; 59(3):280-5. PubMed ID: 9522945
[TBL] [Abstract][Full Text] [Related]
5. Antipyrine metabolism in the Venda.
Sommers DK; Moncrieff J; Avenant JC
Hum Toxicol; 1987 Mar; 6(2):127-31. PubMed ID: 3557469
[TBL] [Abstract][Full Text] [Related]
6. The effect of age and sex on metabolism and urinary excretion of antipyrine.
Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
[TBL] [Abstract][Full Text] [Related]
7. Effect of age on the pharmacokinetics of antipyrine in calves.
Janus K; Suszycka J
Res Vet Sci; 1996 May; 60(3):234-7. PubMed ID: 8735513
[TBL] [Abstract][Full Text] [Related]
8. Assay of antipyrine and its main metabolites 3-hydroxymethylantipyrine, norantipyrine and 4-hydroxyantipyrine in urine.
Brendel E; Meineke I; de Mey C
J Pharm Biomed Anal; 1989; 7(12):1783-90. PubMed ID: 2490567
[TBL] [Abstract][Full Text] [Related]
9. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
Rivière JH; Back DJ; Breckenridge AM; Howells RE
Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
[TBL] [Abstract][Full Text] [Related]
11. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
12. Improved high-performance liquid chromatographic assay of antipyrine, hydroxymethylantipyrine, 4-hydroxyantipyrine and norantipyrine in urine.
Mikati MA; Szabo GK; Pylilo RJ; LeDuc BW; Browne TR; Greenblatt DJ
J Chromatogr; 1988 Dec; 433():305-11. PubMed ID: 3235560
[No Abstract] [Full Text] [Related]
13. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine.
Palette C; Cordonnier P; Naline E; Advenier C; Pays M
J Chromatogr; 1991 Jan; 563(1):103-13. PubMed ID: 2061375
[TBL] [Abstract][Full Text] [Related]
14. Influence of short-term water deprivation on antipyrine disposition in calves.
Janus K; Muszczynski Z; Suszycka J
Res Vet Sci; 1997; 63(1):1-3. PubMed ID: 9368948
[TBL] [Abstract][Full Text] [Related]
15. Effect of experimental fasciolosis on antipyrine metabolism and clearance in water buffaloes.
Jiang SX; Bayón JE; Ferre I; Mao XZ; González-Gallego J
Vet Parasitol; 2000 Mar; 88(3-4):177-86. PubMed ID: 10714456
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
Groen K; Breimer DD; van Bezooijen CF
Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
[TBL] [Abstract][Full Text] [Related]
17. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
[TBL] [Abstract][Full Text] [Related]
18. Cimetidine-induced reduction in gastrointestinal absorption of antipyrine and rate constants for formation of its metabolites.
Slusher LB; Vesell ES
Clin Pharmacol Ther; 1984 May; 35(5):568-75. PubMed ID: 6713770
[TBL] [Abstract][Full Text] [Related]
19. Disposition of antipyrine in patients with extensive metastatic liver disease.
Robertz-Vaupel GM; Lindecken KD; Edeki T; Funke C; Belwon S; Dengler HJ
Eur J Clin Pharmacol; 1992; 42(5):465-9. PubMed ID: 1606991
[TBL] [Abstract][Full Text] [Related]
20. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
